Background and recruitment data for the U.S. Diabetes Prevention Program

Diabetes Care

Volumn 23, Issue SUPPL. 2, 2000, Pages

  Fujimoto, Wilfred Y ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIABETES MELLITUS; ETHNIC GROUP; HIGH RISK POPULATION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; LIFESTYLE; MINORITY GROUP; ORAL GLUCOSE TOLERANCE TEST; OUTCOMES RESEARCH; PRIMARY PREVENTION;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; GLUCOSE TOLERANCE TEST; HUMANS; LIFE STYLE; METFORMIN; PATIENT SELECTION; PLACEBOS; RANDOMIZED CONTROLLED TRIALS; UNITED STATES;

EID: 0034033860     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. American Diabetes Association: Diabetes 1996: Vital Statistics. Alexandria, VA, American Diabetes Association, 1996
2. National Institutes of Health: National Diabbetes Fact Sheet: National Estimates and General Information on Diabetes in the United States. Bethesda, MD, National Institutes of Health, 1997
3. Javitt JC, Chiang YP: Economic impact of diabetes. In Diabetes in America. 2nd ed. Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, Eds. Washington, DC, U.S. Govt. Printing Office, 1995, p. 601-611 (NIH publ. no. 95-1468)
4. American Diabetes Association: Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 21:296-309, 1998
5. Rewers M, Hamman RF: Risk factors for non-insulin-dependent diabetes. In Diabetes in America. 2nd ed. Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH, Eds. Washington, DC, U.S. Govt. Printing Office, 1995, p. 179-220 (NIH publ. no. 95-1468)
6. Sartor G, Schersten B, Carlstrom S, Melander A, Norden A, Persson G: Ten-year follow-up of subjects with impaired glucose tolerance: prevention of diabetes by tolbutamide and diet regulation. Diabetes 29:41-44, 1980
7. Eriksson KF, Lindgarde F: Prevention of type II (non-insulin-dependent) diabetes mellitus by diet and physical exercise: the 6-year Malmo Feasibility Study. Diabetologia 34:891-898, 1991
8. Bourn DM, Mann JI, McSkimming BJ, Waldron MA, Wishart JD: Impaired glucose tolerance and NIDDM: does lifestyle intervention program have an effect? Diabetes Care 17:1311-1319, 1994
9. Nolan JJ, Ludvik B, Beerdsen P, Joyce M, Olefsky J: Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med 331:1188-1193, 1994
10. The Diabetes Prevention Program Research Group. The Diabetes Prevention Program: design and methods for a clinical trial in the prevention of type 2 diabetes mellitus. Diabetes Care 22:623-634, 1999
11. Jarrett RJ, Keen H, Fuller JH, McCartney M: Worsening to diabetes in men with impaired glucose tolerance ("borderline diabetes"). Diabetologia 16:25-30, 1979
12. Keen H, Jarrett RJ, McCartney P: The ten-year follow-up of the Bedford survey (1962-1972): glucose tolerance and diabetes. Diabetologia 22:73-78, 1982
13. Edelstein SL, Knowler WC, Bain RP, Andres R, Barrett-Connor EL, Dowse GK, Haffner SM, Pettitt DJ, Sorkin JD, Muller DC, Collins VR, Hamman RF: Predictors of progression from impaired glucose tolerance to non-insulin-dependent diabetes mellitus: an analysis of six prospective studies. Diabetes 46:701-710, 1997
14. American Diabetes Association: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 21 (Suppl. 1):S5-S19, 1998